Athira Pharma Inc. (ATHA)
NASDAQ: ATHA
· Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM
Athira Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -79.75M | -96.94M | -109.22M | -113.45M | -116.19M | -117.67M | -120.52M | -107.74M | -102.48M | -95.64M | -81.84M | -77.33M | -66.97M | -54.85M | -46.22M | -39M | -27.02M |
Depreciation & Amortization | 418K | 482K | 484K | 973K | 975K | 969K | 963K | 950K | 927K | 845K | 732K | 624K | 521K | 479K | 604K | 481K | 363K |
Stock-Based Compensation | 10.01M | 11.05M | 11.05M | 10.61M | 10.52M | 10.62M | 10.76M | 10.68M | 10.66M | 10.61M | 9.68M | 8.37M | 6.38M | 4.62M | 3.6M | 2.61M | 1.55M |
Other Working Capital | -15.09M | -14.02M | 1.29M | 768K | 1.68M | 1.9M | 11.81M | 9.34M | 8.48M | 8.36M | -10.41M | -3.56M | 1.84M | 1.38M | 198.01M | 191.74M | 185.74M |
Other Non-Cash Items | 4.36M | 10.57M | 14.45M | 12.47M | 10.23M | 3.74M | -479K | -687K | -693K | -228K | 224K | 499K | 547K | 493K | -3.88M | -2.83M | -3.18M |
Deferred Income Tax | n/a | n/a | -4.14M | -4.53M | -4.94M | -4.94M | -800K | -406K | n/a | n/a | n/a | n/a | n/a | n/a | 4.14M | 4.14M | 4.14M |
Change in Working Capital | -11.33M | -13.52M | -1.25M | 4.34M | 5.45M | 6.53M | 19.96M | 9.42M | 9.49M | 11.94M | -3.78M | 4.19M | 7.15M | 6.16M | 6.16M | -109K | -6.11M |
Operating Cash Flow | -86.03M | -97.17M | -97.45M | -98.41M | -100.36M | -100.75M | -90.13M | -87.78M | -82.09M | -72.47M | -74.98M | -63.64M | -52.37M | -43.1M | -35.59M | -34.7M | -30.24M |
Capital Expenditures | -28K | -33K | -33K | -63K | -68K | -304K | -305K | -519K | -637K | -1.14M | -2.17M | -2.05M | -2.01M | -1.57M | -2.8M | -2.74M | -2.62M |
Cash Acquisitions | n/a | n/a | 89K | 68.28K | 35.76K | n/a | -113.65K | -106.81K | -74.29K | -38.52K | -18.07M | -18.05M | -18.05M | -18.05M | -68K | -68K | -68K |
Purchase of Investments | -18.42M | -14.13M | -11.32M | -14.1M | -23.87M | -27.67M | -37.84M | -68.51M | -87.17M | -95.29M | -114.94M | -177.3M | -223.88M | -299.2M | -401.93M | -400.4M | -319.98M |
Sales Maturities Of Investments | 52.89M | 69M | 75.39M | 80.85M | 96.55M | 123.06M | 151.49M | 175.31M | 157.15M | 154.09M | 171.49M | 205.91M | 268.37M | 296.69M | 263.52M | 181.78M | 89.79M |
Other Investing Acitivies | 26.59M | 39.64M | 39.64M | 39.66M | 13.11M | 95.39K | 113.65K | 106.81K | -4.24M | 20.32M | 38.35M | 24.26M | 40.14M | -6.85M | -24.84M | -10.8M | -22.37M |
Investing Cash Flow | 34.44M | 54.83M | 64.03M | 66.68M | 72.61M | 95.09M | 113.34M | 106.29M | 69.34M | 57.66M | 54.39M | 26.56M | 42.48M | -4.08M | -141.21M | -221.32M | -232.78M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -260K | -260K | -260K | -260K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 194K | 194K | 312K | 300K | 394K | 493K | 488K | 488K | 543K | 654K | 520K | 645K | 498K | 327K | 344K | 748K | 85.9M |
Financial Cash Flow | 194K | 194K | 312K | 300K | 394K | 493K | 488K | 488K | 543K | 654K | 520K | 645K | 88K | 97.09M | 118.4M | 302.56M | 388.12M |
Net Cash Flow | -51.4M | -42.15M | -33.1M | -31.43M | -27.36M | -5.17M | 23.71M | 18.99M | -12.21M | -14.15M | -20.07M | -36.43M | -9.8M | 49.91M | -58.4M | 46.53M | 125.1M |
Free Cash Flow | -86.06M | -97.2M | -97.48M | -98.47M | -100.43M | -101.06M | -90.43M | -88.3M | -82.73M | -73.61M | -77.15M | -65.69M | -54.38M | -44.67M | -38.39M | -37.44M | -32.87M |